Article
Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides.
Immunity - 1 Dec 1994
Alexander J, Sidney J, Southwood S, Ruppert J, Oseroff C, Maewal A, Snoke K, Serra H M, Kubo R T, Sette A
Abstract excerpt
Pan DR-binding peptides engineered by introducing anchor residues for different DR motifs within a polyalanine backbone bound 10 of 10 DR molecules tested, with affinities, in most cases, in the nanomolar range. Because of the small methyl group exposed for T cell recognition, these peptides were poor immunogens but effective blockers of DR-restricted antigen presentation. Introduction of bulky and charged...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
